Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Natural History of Disorders Screenable in the Newborn…

U.S. National Institutes of Health·United States of America

Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)

Rolling / TBD close$500k – $2MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

This funding opportunity announcement (FOA) encourages applications that propose to develop studies leading to a broad understanding of the natural history of disorders that already do or could potentially benefit from early identification by newborn screening. The goal is to facilitate appropriate interventions for infants identified by newborn screening. Key aspects of the project include: * Developing studies to understand the natural history of disorders * Identifying genotype-phenotype correlations to predict clinical course * Identifying modifying genetic, epigenetic, or environmental factors to enhance understanding of clinical outcomes * Providing accurate diagnosis, understanding genetic and clinical heterogeneity, and identifying underlying mechanisms * Potentially preventing, managing, and treating symptoms and complications * Providing children and their families with needed support and predictive information about the disorder. Some of the key eligibility criteria include: * Alaska Native and Native Hawaiian Serving Institutions * Asian American Native American Pacific Islander Serving Institutions * Eligible Agencies of the Federal Government * Faith-based or Community-based Organizations * Hispanic-serving Institutions * Historically Black Colleges and Universities * Indian/Native American Tribal Governments * Non-domestic (non-U.S.) Entities * Regional Organizations * Tribally Controlled Colleges and Universities * U.S. Territory or Possession

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
2/8/2021
Closes
Rolling / TBD

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PAR-21-115

Budget estimate

$500,000 – $2,000,000

The estimated budget for this grant is difficult to determine, as the document does not provide a specific award amount. However, based on the scope of the project, which involves researching the natural history of disorders, the estimated budget could be in the range of $500,000 to $2 million. This estimate is based on the assumption that the project will require significant resources, including personnel, equipment, and materials, to conduct the research. Factors that may influence the likely payment range include the complexity of the research, the number of participants, and the duration of the project.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 85%

Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 2/8/2021

U.S. National Institutes of Health·United States of America

81% match

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

Closes 11/16/2027Opened 12/2/2024

U.S. National Institutes of Health·United States of America

78% match

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

Closes 11/16/2027Opened 12/2/2024

U.S. National Institutes of Health·United States of America

70% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Institutes of Health·United States of America

69% match

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

Closes 11/5/2028Opened 12/30/2024

U.S. National Institutes of Health·United States of America

68% match

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/30/2024

U.S. National Institutes of Health·United States of America

68% match

Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

68% match

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029Opened 9/10/2025

U.S. National Institutes of Health·United States of America

67% match

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Closes 7/20/2028Opened 6/9/2025

U.S. National Institutes of Health·United States of America

67% match

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. Food and Drug Administration·United States of America

67% match

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

67% match

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

Closes 2/3/2027Opened 4/1/2024

U.S. National Institutes of Health·United States of America

67% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

66% match

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Closes 11/2/2026Opened 11/6/2023

U.S. National Institutes of Health·United States of America

66% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

Michigan Department of Health and Human Services – Bureau of Laboratories·Michigan

66% match

Mayo Medical Laboratories (MML)- Second tier testing for NBS

Closes 11/2/2026Opened 10/26/2026

U.S. National Institutes of Health·United States of America

66% match

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

Closes 2/3/2027Opened 4/2/2024

U.S. National Institutes of Health·United States of America

66% match

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 5/5/2020

U.S. Food and Drug Administration·United States of America

66% match

Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

Rolling / TBD closeOpened 7/11/2025

U.S. Department Of Defense·Florida

66% match

Newborn Screenings

Closes 11/9/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

66% match

NIH Research Program Projects (Parent P01 Clinical Trial Optional)

Closes 5/25/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

66% match

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

Closes 1/6/2028Opened 12/22/2021

U.S. National Institutes of Health·United States of America

66% match

Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)

Closes 9/9/2027Opened 9/20/2024

U.S. Food and Drug Administration·United States of America

66% match

Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

Rolling / TBD closeOpened 7/11/2025

U.S. National Institutes of Health·United States of America

66% match

Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)

Closes 2/26/2027Opened 12/16/2024